Moreover, overexpression of cellular MET (c-MET)/MET has been documented in diverse malignancies, including NSCLC, hepatocellular carcinoma, gastroesophageal cancer, and gliomas, further emphasizing their role in oncogenesis [29, 35–37]. The gene discussed is MET; the disease is non-small cell lung carcinoma.